Janice P Dutcher (J P Dutcher)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Metastatic Renal Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer immunology, immunotherapy : CII

Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Wenxin Xu, Mäneka Puligandla, Brian Halbert, Naomi B Haas, Keith T Flaherty, Robert G Uzzo, Janice P Dutcher, Robert S DiPaola, Venkata Sabbisetti, Rupal S Bhatt
Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805). Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Joseph I Clark, Brendan Curti, Elizabeth J Davis, Howard Kaufman, Asim Amin, Ajjai Alva, Theodore F Logan, Ralph Hauke, Gerald P Miletello, Ulka Vaishampayan, Douglas B Johnson, Richard L White, Peter H Wiernik, Janice P Dutcher
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2. Journal of investigative medicine : the official publication of the American Federation for Clinical Research (2021)
M Fishman, Janice P Dutcher, J I Clark, A Alva, G P Miletello, B Curti, Neeraj Agarwal, R Hauke, K M Mahoney, H Moon, J Treisman, S S Tykodi, G Daniels, M A Morse, M K K Wong, H Kaufman, N Gregory, D F McDermott
Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry. Journal for immunotherapy of cancer 7 (1) (2019)
Janice P Dutcher
"Pseudoprogression": more than semantics. Cancer immunology, immunotherapy : CII 67 (9) (2018)
Janice P Dutcher, Peter H Wiernik
Interleukin-2 Can Cure Kidney Cancer. The oncologist 23 (9) (2018)